The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO)

被引:53
作者
Casali, P. G. [1 ]
机构
[1] Ist Nazl Tumori, ESMO, I-20133 Milan, Italy
关键词
D O I
10.1093/annonc/mdm517
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1923 / 1925
页数:3
相关论文
共 11 条
[2]   Off label use-label off use? [J].
Boos, J .
ANNALS OF ONCOLOGY, 2003, 14 (01) :1-5
[3]   Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children [J].
Conroy, S ;
Newman, C ;
Gudka, S .
ANNALS OF ONCOLOGY, 2003, 14 (01) :42-47
[4]   European perspective on the costs and cost-effectiveness of cancer therapies [J].
Drummond, Michael F. ;
Mason, Anne R. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (02) :191-195
[5]  
EUDRAL, RULES GOVERNING MED
[6]   The advisory process for anticancer drug regulation: a global perspective [J].
Farrell, AT ;
Papadouli, I ;
Hori, A ;
Harczy, M ;
Harrison, B ;
Asakura, W ;
Marty, M ;
Dagher, R ;
Pazdur, R .
ANNALS OF ONCOLOGY, 2006, 17 (06) :889-896
[7]  
Graul AI, 2007, DRUG NEWS PERSPECT, V20, P45
[8]  
Kocs D, 2003, AM J MANAG CARE, V9, P393
[9]   REIMBURSEMENT POLICIES CONSTRAIN THE PRACTICE OF ONCOLOGY [J].
LAETZ, T ;
SILBERMAN, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (21) :2996-2999
[10]   ASCO-ESMO consensus statement on quality cancer care [J].
Ludwig, Heinz ;
Mok, Tony ;
Stovall, Ellen ;
Ganz, Patricia ;
Armitage, James ;
Catane, Raphael ;
Adamou, Adamos ;
Redmond, Kathy .
ANNALS OF ONCOLOGY, 2006, 17 (07) :1063-1064